Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 11/20 | 0.46 |
| ▸ | ABHD6 | Q9BV23 | 8/20 | 0.46 |
| ▸ | PLA2G7 | Q13093 | 6/20 | 0.46 |
| ▸ | MC4R | P32245 | 2/20 | 0.37 |
| ▸ | DDR1 | Q08345 | 1/20 | 0.35 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.35 |
| ▸ | HTR3B | O95264 | 1/20 | 0.35 |
| ▸ | HTR3A | P46098 | 1/20 | 0.35 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.35 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18064849 | 0.85 | MGLL (0.61) | MGLLABHD6PLA2G7 | |
| SCHEMBL15094567 | 0.85 | MGLL (0.44) | MGLLABHD6PLA2G7DDR1 | |
| SCHEMBL15094637 | 0.84 | MGLL (0.46) | MGLLABHD6PLA2G7CYP2D6 | |
| SCHEMBL15094753 | 0.83 | MGLL (0.39) | MGLLABHD6PLA2G7 | |
| SCHEMBL15094622 | 0.82 | MGLL (0.50) | MGLLABHD6PLA2G7 | |
| SCHEMBL15094719 | 0.81 | MGLL (0.45) | MGLLABHD6PLA2G7MC4R | |
| SCHEMBL15094825 | 0.80 | MGLL (0.55) | MGLLABHD6PLA2G7CYP2D6 | |
| Hydrochloric Acid SCHEMBL20167952 | 0.79 | MGLL (0.54) | MGLLABHD6PLA2G7CYP2D6 | |
| SCHEMBL29170864 | 0.79 | MGLL (0.43) | MGLLABHD6PLA2G7 | |
| SCHEMBL19974350 | 0.79 | MGLL (0.41) | MGLLABHD6PLA2G7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017143283-A1 | RADIOLABELED MONOACYLGLYCEROL LIPASE OCCUPANCY PROBE | ABIDE THERAPEUTICS, INC. (US) | 2017-08-24 | — | — | WO | disclosed |